GuruFocus DCF Puts Monster Intrinsic Value at $44, Highlighting Extreme Overvaluation

What happened

On May 27, 2026, GuruFocus published a DCF analysis for Monster Beverage, estimating an intrinsic value of $44 per share against a current market price of $87. The report underscores that the stock is trading at nearly double its calculated fair value, even after a strong run-up from the $75 level seen in early March. This analysis aligns with the DeepValue Master Report's 'WAIT' rating, which already flagged the stock as overvalued at $75.61 with an attractive entry near $68. The DCF adds a fresh, independent data point confirming that the market is pricing in optimistic growth and margin assumptions that may not materialize given rising aluminum costs and tariff headwinds. Investors should note that the stock has rallied further since the master report, making the risk-reward even less favorable.

Implication

For investors, the DCF analysis provides a sobering counterpoint to the bullish narrative that has driven MNST to $87. The $44 intrinsic value implies a 49% downside if the market reprices to fair value, though such a move is unlikely without a catalyst. The master report's 'WAIT' rating and attractive entry of $68 remain relevant, but the current price is now well above that level. Given the master report's base case of $78 and bear case of $60, the stock's advance above $80 reduces the margin of safety further. Investors should not chase the rally; instead, they should wait for either a pullback to the $68-$78 range or for evidence that gross margins can hold above 55% despite cost pressures. The DCF highlights that even if the company executes well, the current price leaves little room for error, and any earnings miss could trigger a sharp revaluation.

Thesis delta

The DCF analysis sharpens the overvaluation signal from the master report, which already rated MNST a 'WAIT' at $75.61. With the stock now at $87 and intrinsic value estimated at $44, the gap between price and fundamental value has widened substantially. This increases the probability of mean reversion and lowers the risk-adjusted return potential, reinforcing the view that investors should wait for a lower entry point.